Groowe Groowe / Newsroom / IGC
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

IGC News

IGC Pharma, Inc.

IGC Pharma Reaches Previously Disclosed 146-Patient Enrollment Target in Phase 2 CALMA Trial, Advancing Toward Topline Analysis

accessnewswire.com
IGC

Ascendiant Capital Markets Raises IGC Pharma Price Target to $5.50, Citing Clinical Progress and 2026 Catalysts

accessnewswire.com
IGC

Form 8-K

sec.gov
IGC

IGC Pharma Adds Mount Sinai Clinical Site as CALMA Trial Advances Toward Completion and Topline Analysis

accessnewswire.com
IGC

New to The Street Broadcasts Nationwide on Bloomberg Television Featuring "Opportunities To Consider(TM)" Across Artificial Intelligence, Healthcare Innovation, Fintech, Digital Assets, and Commodities

accessnewswire.com
LTRN RDZN HIT DVLT GROY MDCX IGC

Joint Press Release of Future Fuels Inc And Valore Metals Corp. - Future Fuels Completes Acquisition of Hatchet Uranium Corp.

accessnewswire.com
IGC RIO

New to The Street Broadcasts Episode 753 Today at 6:30 PM EST Across Bloomberg Television U.S., MENA, and Latin America Featuring Leaders in VR Defense Training, AI Streaming, Healthcare Innovation, and Global Workforce Technology

accessnewswire.com
VTIX MDCX YYGH DVLT LTRN RDZN IGC

IGC Pharma Reports First Quarter 2026 Financial Results with CALMA Phase 2 in the final stage, with 80% Enrollment

accessnewswire.com
IGC

New to The Street's Show #753 Airs Nationwide on Bloomberg Television Across the U.S., MENA and Latin America Featuring FreeCast (NASDAQ:CAST), Stardust Power (NASDAQ:SDST), Lost Soldier Oil and Gas, Virtuix Holdings (NASDAQ:VTIX), and Medicus Pharma

accessnewswire.com
CAST SDST VTIX MDCX IGC NRXP DVLT

IGC Pharma to Present Tau-PET Biomarker Research at 2026 Global Tau Conference

accessnewswire.com
IGC